Material Name: Neurontin (gabapentin) Oral Solution Trade Name: NEURONTIN Chemical Family: Mixture Intended Use: Pharmaceutical product used as anticonvulsant 2. HAZARDS IDENTIFICATION Appearance: Clear, colorless liquid Statement of Hazard: Non-hazardous in accordance with international standards for workplace safety. Additional Hazard This Safety Data Sheet contains 16 sections. All 16 sections must be present for this document to be valid. The most important known symptoms and effects are described in the labeling (see section 2.2) and/or section 11. Product name : Gabapentin Catalog No. : HY-A0057 CAS No. : 60142-96-3 1.2 Relevant identified uses of the substance or mixture and uses advised against Identified uses : Laboratory chemicals, manufacture of substances. 1.3 Details of the supplier of the safety data sheet Company: MedChemExpress USA Tel: 609-228-6898 Fax: 609-228-5909 Material Safety Data Sheet . Material Name: Gabapentin Oral Solution, 250 mg / 5 mL _____ Page 2 of 5 Issue Date: 02/16/12 Revision: 1.0000 Print Date: 2/16/2012 . First Aid: Inhalation. Remove the person from the exposed area to fresh air immediately. Product name : Gabapentin CBnumber : CB3263316 CAS : 60142-96-3 EINECS Number : 262-076-3 Synonyms : gabapentin,gabapentine Relevant identified uses : For R&D use only. Not for medicinal, household or other use. Uses advised against : none Company : Chemicalbook Address : Building 1, Huihuang International, Shangdi 10th Street, Haidian District MATERIAL SAFETY DATA SHEET Version: 1.3 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Material Name: Neurontin (gabapentin) Oral Solution Trade Name: NEURONTIN(R) Chemical Family: Mixture Intended Use: Pharmaceutical product used as anticonvulsant 2. COMPOSITION/INFORMATION ON INGREDIENTS Hazardous Oral Solution are supplied as imprinted hard shell capsules containing 100 mg, 300 mg, and 400 mg of gabapentin, elliptical film-coated tablets containing 600 mg and 800 mg of gabapentin or Material Safety Data Sheet . Material Name: Gabapentin Oral Solution, 250 mg / 5 mL _____ Page 5 of 5 Issue Date: 02/16/12 Revision: 1.0000 Print Date: 2/16/2012 . Additional Regulatory Information. Component Analysis - Inventory. Component CAS # TSCA CAN EEC Water 7732-18-5 Yes DSL EINECS Gabapentin 60142-96-3 No No EINECS These highlights do not include all the information needed to use GABAPENTIN ORAL SOLUTION safely and effectively. See full prescribing information for GABAPENTIN ORAL SOLUTION. GABAPENTIN oral solution Initial U.S. Approval: 1993 INDICATIONS AND USAGE Gabapentin oral solution is indicated for: • Postherpetic neuralgia in adults ( 1) These highlights do not include all the information needed to use GABAPENTIN ORAL SOLUTION safely and effectively. See full prescribing information for GABAPENTIN ORAL SOLUTION. GABAPENTIN oral solution Initial U.S. Approval: 1993 INDICATIONS AND USAGE Gabapentin oral solution is indicated for: Postherpetic neuralgia in adults (1) Gabapentin 60142-96-3 100 4. First-aid measures General Advice Show this safety data sheet to the doctor in attendance. Immediate medical attention is required. Eye Contact Rinse immediately with plenty of water, also under the eyelids, for at least 15 minutes. In Each SolutionKitsTM – Gabapentin Compounding Kit contains: (i) 22.5 g of gabapentin powder USP; (ii) 440 mL of oral suspension vehicle, and (iii) 1 Plastic Funnel for Compounding. Using the kit and following the directions provided results in an oral suspension of 450mL containing 50 mg/mL of gabapentin oral solution. Contents NDC 46144-600-01 SDS: Gabapentin Oral Solution 4 of 7 Respiratory Protection: Where respirators are deemed necessary to reduce or control occupational exposures, use NIOSH-approved respiratory protection and have an effective respirator program in place (applicable U.S. regulation OSHA 29 CFR 1910.134). Material Name: Neurontin (gabapentin) Oral Solution Trade Name: NEURONTIN Chemical Family: Mixture Relevant Identified Uses of the Substance or Mixture and Uses Advised Against Intended Use: Pharmaceutical product used as anticonvulsant Details of the Supplier of the Safety Data Sheet 2. HAZARDS IDENTIFICATION Classification of the Substance or Pfizer Inc believes that the information contained in this Material Safety Data Sheet is accurate, and while it is provided in good faith, it is without a warranty of any kind, expressed or implied. End of Safety Data Sheet Talc (non-asbestiform) Inventory - United States TSCA - Sect. 8(b) Present Australia (AICS): Australia (AICS):Present Present Material Safety Data Sheet . Material Name: Gabapentin Oral Solution, 250 mg / 5 mL _____ Page 5 of 5 Issue Date: 02/16/12 Revision: 1.0000 Print Date: 2/16/2012 . Additional Regulatory Information. Component Analysis - Inventory. Component CAS # TSCA CAN EEC Water 7732-18-5 Yes DSL EINECS Gabapentin 60142-96-3 No No EINECS · Trade name:Gabapentin · Synonym CI-945 1-(aminomethyl)-cyclohexaneacetic acid · Article number:10008346 · CAS Number: 60142-96-3 · EC number: 262-076-3 · Application of the substance / the mixture This product is for research use - Not for human or veterinary diagnostic or therapeutic use. · Details of the supplier of the safety data sheet SOLUTION safely and effectively. See full prescribing information for GABAPENTIN ORAL SOLUTION. GABAPENTIN oral solution Initial U.S. Approval: 1993 RECENT MAJOR CHANGES Warnings and Precautions, Respiratory Depression ( 5.7) 04/2020 INDICATIONS AND USAGE Gabapentin oral solution is indicated for: Postherpetic neuralgia in adults ( 1) 52 Week(s) Monkey Oral 250 mg/kg/day NOAEL None identified Rat Oral LD50 100 g/kg Gabapentin 13 Week(s) Mouse Oral 1000 mg/kg/day NOAEL No effects at maximum dose 2 Year(s) Mouse Oral, in feed 2000 mg/kg/day NOEL Not carcinogenic Rat Inhalation LC50 > 2000 mg/m3 SDS: Gabapentin Oral Solution 1 of 7 SAFETY DATA SHEET 1. Identification Product Identifier: Gabapentin Oral Solution Synonyms: Cyclohexaneacetic acid, 1-(aminomethyl)- National Drug Code (NDC): 50383-311-07 50383-311-09 50383-311-47 Recommended Use: Pharmaceutical. Company: Akorn, Inc. 1925 West Field Court, Suite 300
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |